- Home
- PTGX vs SKT Comparison
PTGX vs SKT Comparison
Compare PTGX & SKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- SKT
- Stock Information
- Founded
- PTGX 2006
- SKT 1981
- Country
- PTGX United States
- SKT United States
- Employees
- PTGX 130
- SKT N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- SKT Real Estate Investment Trusts
- Sector
- PTGX Health Care
- SKT Real Estate
- Exchange
- PTGX Nasdaq
- SKT Nasdaq
- Market Cap
- PTGX 5.0B
- SKT 3.9B
- IPO Year
- PTGX 2016
- SKT 1993
- Fundamental
- Price
- PTGX $79.54
- SKT $34.46
- Analyst Decision
- PTGX Strong Buy
- SKT Buy
- Analyst Count
- PTGX 9
- SKT 9
- Target Price
- PTGX $86.22
- SKT $37.00
- AVG Volume (30 Days)
- PTGX 1.3M
- SKT 855.6K
- Earning Date
- PTGX 11-06-2025
- SKT 11-04-2025
- Dividend Yield
- PTGX N/A
- SKT 3.39%
- EPS Growth
- PTGX N/A
- SKT 8.00
- EPS
- PTGX 0.72
- SKT 0.94
- Revenue
- PTGX $209,217,000.00
- SKT $575,140,000.00
- Revenue This Year
- PTGX N/A
- SKT $2.56
- Revenue Next Year
- PTGX $140.23
- SKT $4.65
- P/E Ratio
- PTGX $110.77
- SKT $36.69
- Revenue Growth
- PTGX N/A
- SKT 10.01
- 52 Week Low
- PTGX $33.31
- SKT $28.69
- 52 Week High
- PTGX $93.25
- SKT $37.57
- Technical
- Relative Strength Index (RSI)
- PTGX 62.21
- SKT 63.20
- Support Level
- PTGX $75.44
- SKT $33.22
- Resistance Level
- PTGX $80.43
- SKT $34.84
- Average True Range (ATR)
- PTGX 2.61
- SKT 0.79
- MACD
- PTGX -0.23
- SKT 0.15
- Stochastic Oscillator
- PTGX 89.38
- SKT 83.64
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.